Home/Oisin Biotechnologies/Henry Garcia, Ph.D.

HG

Henry Garcia, Ph.D.

Head of Aging R&D

Oisin Biotechnologies

Therapeutic Areas

Aging Frailty/Sarcopenia Metabolic Disease Senescence-associated disorders

Oisin Biotechnologies Pipeline

Drug	Indication	Phase
Muscle Growth Program	Frailty/Sarcopenia	Preclinical
Fat Cell Clearance Program	Obesity/Metabolic Dysfunction	Preclinical
Senescent Cell Clearance Program	Senescence-associated diseases	Preclinical

Leadership Team at Oisin Biotechnologies

Chief Executive Officer

John Lewis, Ph.D.

Chief Science Officer

Chief Operating Officer

Stephen Hilbert

Chief Business Officer

Alexandre Gingras, Ph.D.

Head of Preclinical Manufacturing

View full Oisin Biotechnologies profile